STENVAX Trademark

Trademark Overview

On Thursday, March 10, 2011, a trademark application was filed for STENVAX with the United States Patent and Trademark Office. The USPTO has given the STENVAX trademark a serial number of 79095491. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, March 10, 2021. This trademark is owned by Merck KGaA. The STENVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the prevention and treatment of cancer
stenvax

General Information

Serial Number79095491
Word MarkSTENVAX
Filing DateThursday, March 10, 2011
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, March 10, 2021
Registration Number4030642
Registration DateTuesday, September 27, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the prevention and treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, May 4, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck KGaA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address64293 Darmstadt
DE
Party NameMerck KGaA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address64293 Darmstadt
DE
Party NameMerck KGaA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address64293 Darmstadt
DE

Trademark Events

Event DateEvent Description
Sunday, November 7, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, November 7, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, March 8, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Friday, January 18, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, January 18, 2019INVALIDATION PROCESSED
Friday, January 4, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, May 4, 2018CANCELLED SECTION 71
Friday, May 25, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, May 4, 2012FINAL DISPOSITION NOTICE SENT TO IB
Thursday, May 3, 2012FINAL DISPOSITION PROCESSED
Tuesday, December 27, 2011FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 27, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, July 12, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2011PUBLISHED FOR OPPOSITION
Thursday, June 9, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 9, 2011ASSIGNED TO LIE
Saturday, May 28, 2011REFUSAL PROCESSED BY IB
Wednesday, May 25, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 24, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 24, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 24, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 24, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 6, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, May 6, 2011REFUSAL PROCESSED BY MPU
Friday, May 6, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, May 5, 2011NON-FINAL ACTION WRITTEN
Thursday, May 5, 2011ASSIGNED TO EXAMINER
Tuesday, April 26, 2011APPLICATION FILING RECEIPT MAILED
Friday, April 22, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 21, 2011SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

stenvax treatment cancer prevention human preparations pharmaceutical